Refludan

Refludan is a brand name of lepirudin, approved by the FDA in the following formulation(s):

REFLUDAN (lepirudin recombinant - injectable; injection)

• 
  Manufacturer: BAYER HLTHCARE
  
  Approval date: March 6, 1998
  
  Strength(s): 50MG/VIAL ^[RLD]

Has a generic version of Refludan been approved?

No. There is currently no therapeutically equivalent version of Refludan available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Refludan. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Refludan.

See also...

• Refludan Consumer Information (Wolters Kluwer)
• Refludan Consumer Information (Cerner Multum)
• Refludan Advanced Consumer Information (Micromedex)
• Refludan AHFS DI Monographs (ASHP)
• Lepirudin Consumer Information (Wolters Kluwer)
• Lepirudin Consumer Information (Cerner Multum)
• Lepirudin Intravenous Advanced Consumer Information (Micromedex)
• Lepirudin AHFS DI Monographs (ASHP)